AdaptHealth Corp.
NASDAQ:AHCOMedical - Devices
+$0.01 today
- Market cap
- $989.81M
- Beta
- 1.46
- P/E (TTM)
- -16.3
- EPS (TTM)
- -$0.59
Volume 1.71M
Average 1.38M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
AdaptHealth Corp.
NASDAQ:AHCO
Intrinsic Alpha fair value
Locked
Current Price
$7.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +3.0% | +14.1% (5yr)3 analysts |
| Net Income | N/A | N/A | N/A | N/A3 analysts |
| EBIT | N/A | N/A | -0.7% | +3.1% (5yr)3 analysts |
Analysis
Recent growth has been strongest in Revenue at +3.0% over three years. Forward estimates point to Revenue at +14.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
ResMed Inc. NYSE:RMD | $33.69B | $239.53 | Undervalued | 18.1 | -2.37% |
Inspire Medical Systems, Inc. NYSE:INSP | $1.77B | $61.10 | Undervalued | 9.1 | -32.41% |
Tandem Diabetes Care, Inc. NASDAQ:TNDM | $1.40B | $20.07 | Not rated | -11.3 | -13.85% |
Beta Bionics, Inc. NASDAQ:BBNX | $738.73M | $16.42 | Not rated | -9.1 | -53.10% |
Viemed Healthcare, Inc. NASDAQ:VMD | $347.48M | $9.17 | Undervalued | 27.4 | +35.59% |
InfuSystem Holdings, Inc. AMEX:INFU | $294.89M | $14.72 | Undervalued | 23.2 | +52.49% |
Electromed, Inc. AMEX:ELMD | $198.79M | $24.32 | Undervalued | 30.5 | -7.33% |
Inogen, Inc. NASDAQ:INGN | $147.95M | $5.69 | Not rated | -7.0 | -17.75% |
Continue the stock analysis
Jump to another research area for this company.